載入...
CAP—advancing the evaluation of preclinical Alzheimer disease treatments
If we are to find treatments to postpone, reduce the risk of, or completely prevent the clinical onset of Alzheimer disease (AD), we need faster methods to evaluate promising preclinical AD treatments, new ways to work together in support of common goals, and a determination to expedite the initiati...
Na minha lista:
| 發表在: | Nat Rev Neurol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847536/ https://ncbi.nlm.nih.gov/pubmed/26416539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrneurol.2015.177 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|